Eagle Rock Investment Company, LLC Surface Oncology, Inc. Transaction History

Eagle Rock Investment Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	BUY	$0.62 - $1.21 $12,400 - $24,200	20,000 Added 90.91%	42,000 $0
Q3 2022 Nov 08, 2022	SELL	$1.05 - $2.1 $23,100 - $46,200	-22,000 Reduced 50.0%	22,000 $23,000
Q2 2022 Aug 12, 2022	BUY	$1.42 - $3.15 $31,240 - $69,300	22,000 Added 100.0%	44,000 $72,000
Q4 2021 Feb 17, 2022	BUY	$4.73 - $7.9 $104,060 - $173,800	22,000 New	22,000 $105,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Eagle Rock Investment Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Rock Investment Company, LLC with notifications on news.